Robert Chadband
Endocrinology, Diabetes & Metabolism · Cullman, ALNPI 1134181431
Payments from drug & device makers
Across 134 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$469
- Medtronic$251
- Amgen$249
- AstraZeneca$148
- Lilly USA, LLC$144
- Sanofi-aventis U.S. LLC$135
- plus $866 from 26 others
What the payments were for
- Food & beverage$2,24599%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 31 | $469 |
| Medtronic(2 entities) | 12 | $251 |
| Amgen | 16 | $249 |
| AstraZeneca | 7 | $148 |
| Lilly USA, LLC | 9 | $144 |
| Sanofi-aventis U.S. LLC | 4 | $135 |
| Corcept Therapeutics | 6 | $101 |
| Xeris Pharmaceuticals, Inc. | 5 | $84 |
| AbbVie | 4 | $69 |
| Merck | 4 | $59 |
| IBSA Pharma Inc. | 3 | $54 |
| Boehringer Ingelheim | 3 | $51 |
| Grifols USA, LLC | 3 | $48 |
| Johnson & Johnson | 3 | $39 |
| OPKO Pharmaceuticals, LLC | 3 | $36 |
| Novartis | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| Shire North American Group Inc | 2 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| Dexcom, Inc. | 1 | $19 |
| Sobi, Inc | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| GRT US Holding, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $14 |
| GSK | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
How this compares
$2,263 in reported general payments places this provider in the 20th percentile of 79 endocrinology, diabetes & metabolism providers in Alabama.
See all endocrinology, diabetes & metabolism providers in Alabama →
Other endocrinology, diabetes & metabolism in Cullman
- William GarveyBirmingham$3.8M
- Neil SchaffnerOpelika$642K
- Fernando OvalleBirmingham$516K
- Ralph TeagueBirmingham$487K
- Bantwal BaligaOpelika$483K
- Judson MenefeeFairhope$185K
- Amy WarrinerBirmingham$182K
- William DebellTuscaloosa$161K
- Edison GoncalvesBirmingham$142K
- Bruce TrippeDothan$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.